Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.4700
+0.0100 (2.17%)
At close: Mar 31, 2026
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 193.26 million as of March 31, 2026. Its market cap has increased by 371.67% in one year.
Market Cap
193.26M
Enterprise Value
175.80M
Revenue
14.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 193.26M, an increase of 286.53%. That is a compound annual growth rate of 5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 193.26M | 28.36% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 442.19M |
| Tetratherix | 210.68M |
| Orthocell | 196.70M |
| Dimerix | 177.12M |
| Recce Pharmaceuticals | 133.02M |
| Amplia Therapeutics | 123.14M |
| Actinogen Medical | 118.52M |
| Paradigm Biopharmaceuticals | 115.68M |